Brain Cancer News and reporting on brain cancer. May 17, 2022 Routine Genomic Profiling Could Improve Diagnosis of Aggressive Brain Cancers, Patient Outcomes Premium May 2, 2022 Brain Cancer Canada Funds Development of New Dx Sequencing Assay at St. Michael's Hospital Apr 18, 2022 Black Diamond Therapeutics Doses First Patient in Recurrent EGFR-Mutant Glioblastoma, NSCLC Trial Apr 14, 2022 Mustang Bio to Study CAR T-Cell, Oncolytic Virus Combination for Recurrent Brain Cancer Patients Mar 21, 2022 NIH Launches New Childhood Cancer Genomics Program Mar 9, 2022 Cellevolve Bio, Seattle Children's Therapeutics Ink CAR-T Pact Focused on Pediatric Brain Cancer Feb 23, 2022 National Brain Tumor Society, Yale Cancer Center Researching DNA Damage Response in Brain Cancers Feb 16, 2022 Rozlytrek Studies Show Durable Responses in Patients With Brain Metastases Premium Feb 15, 2022 Lantern Pharma Working With Greehey Children's Cancer Research Institute To ID New Uses for Drugs Dec 16, 2021 Denovo Biopharma IDs Genetic Biomarker to Predict Brain Cancer Gene Therapy Response Aug 16, 2021 FDA Approves Merck's Welireg for Certain Von Hippel-Lindau-Associated Cancers Jun 9, 2021 Prediction Model IDs Brain Cancer Features That Contribute to Survival After CAR T-Cell Therapy May 20, 2021 Mustang Bio Initiates CAR T-Cell Therapy in Phase I Brain Tumor Trial Mar 31, 2021 Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay Premium Mar 22, 2021 Berg Advances BPM31510, Applies AI Platform to Biomarker Search in Phase II Brain Cancer Trial Premium Mar 10, 2021 Datar Cancer Genetics Obtains CE Mark for Liquid Biopsy Cancer Test Jan 11, 2021 Glioblastoma Transcriptomes Point to Mitochondrial Subtype, Potential Treatment Strategies Dec 23, 2020 Bristol Myers Unblinds Trial After Opdivo, Chemoradiation Fail to Extend Survival in Glioblastoma Dec 22, 2020 Mustang Bio, City of Hope Initiate Clinical Trial of CAR T-cell Therapy in Brain Cancer Patients Sep 23, 2020 Novellus Raises $57M in Series C Funding Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
